Directorate Change
, category: Board changes
Download PDF(opens in a new tab)GCP Infrastructure Investments Limited
("GCP Infra" or the "Company")
LEI: 213800W64MNATSIV5Z47
Headline: Directorate Change
13 February 2020
As announced on 17 September 2019, Clive Spears notified the Board of his intention to retire as a Non-Executive Director at the Company's Annual General Meeting. Following the conclusion of today's Annual General Meeting, we confirm that Clive Spears has retired with effect from today, 13 February 2020.
Ian Reeves CBE, Chairman, commented, "I would like to thank Clive for his invaluable support, dedicated service and contribution to the Group over the last 9 years. The Board would like to wish Clive continued success in the future".
For further information please contact:
|
GCP Infrastructure Investments Limited Company Secretary, Apex Financial Services (Alternative Funds) Limited |
+44 (0)1534 847000 |
|
Gravis Capital Management Limited Dion Di Miceli Philip Kent |
+44 (0)20 3405 8500 |
|
Stifel Nicolaus Europe Limited Mark Bloomfield Nick Donovan |
+44 (0)20 7710 7600 |
|
Buchanan/Quill Helen Tarbet Sarah Gibbons-Cook Henry Wilson |
+44 (0)20 7466 5000 |
Notes to the Editor
About GCP Infra
GCP Infra is a closed-ended investment company and FTSE-250 constituent whose shares are traded on the main market of the London Stock Exchange. Its objective is to provide shareholders with regular, sustained, long-term distributions and to preserve capital over the long term by generating exposure to UK infrastructure debt and related and/or similar assets. The Company primarily targets investments in infrastructure projects with long term, public sector-backed, availability-based revenues. Where possible, investments are structured to benefit from partial inflation protection. GCP Infra is advised by Gravis Capital Management Limited.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.